School and Community Screening Shows Malawi, Africa, to Have a High Prevalence of Latent Rheumatic Heart Disease

Rheumatic heart disease (RHD) is the largest cardiac cause of morbidity and mortality in the world's youth. Early detection of RHD through echocardiographic screening in asymptomatic children may identify an early stage of disease, when secondary prophylaxis has the greatest chance of stopping disease progression. Latent RHD signifies echocardiographic evidence of RHD with no known history of acute rheumatic fever and no clinical symptoms.

OBJECTIVE: Determine the prevalence of latent RHD among children ages 5-16 in Lilongwe, Malawi.

DESIGN: This is a cross-sectional study in which children ages 5 through 16 were screened for RHD using echocardiography.

SETTING: Screening was conducted in 3 schools and surrounding communities in the Lilongwe district of Malawi between February and April 2014.

OUTCOME MEASURES: Children were diagnosed as having no, borderline, or definite RHD as defined by World Heart Federation criteria. The primary reader completed offline reads of all studies. A second reader reviewed all of the studies diagnosed as RHD, plus a selection of normal studies. A third reader served as tiebreaker for discordant diagnoses. The distribution of results was compared between gender, location, and age categories using Fisher's exact test.

RESULTS: The prevalence of latent RHD was 3.4% (95% CI = 2.45, 4.31), with 0.7% definite RHD and 2.7% borderline RHD. There was no significant differences in prevalence between gender (P = .44), site (P = .6), urban vs. peri-urban (P = .75), or age (P = .79). Of those with definite RHD, all were diagnosed because of pathologic mitral regurgitation (MR) and 2 morphologic features of the mitral valve. Of those with borderline RHD, most met the criteria by having pathological MR (92.3%).

CONCLUSION: Malawi has a high rate of latent RHD, which is consistent with other results from sub-Saharan Africa. This study strongly supports the need for a RHD prevention and control program in Malawi.

Oclusão percutânea do apêndice auricular esquerdo e estrutura auricular: efeito na função mecânica e endócrina auricular

Mestrado em Tecnologia de Diagnóstico e Intervenção Cardiovascular - Área de especialização: Intervenção Cardiovascular.

Agrandissement des feuillets mitraux en insuffisance aortique : un mécanisme actif pouvant prévenir l’insuffisance mitrale dans le ventricule dilaté

L’insuffisance mitrale (IM) fonctionnelle est une complication fréquente des cardiopathies, causée par la dilatation du ventricule gauche (VG) qui empêche la valve de se fermer. L’insuffisance aortique (IA) est une condition associée à des valves mitrales (VM) inhabituellement grandes, et relativement peu d’IM malgré des VG très dilatés. Cet élargissement de la VM a le potentiel de prévenir l’IM dans les VG dilatés. Les mécanismes sont cependant peu compris : il n’est pas clair s’il s’agit d’une croissance active ou d’un étirement passif des feuillets. Également, le timing de l’adaptation valvulaire n’est pas connu. Notre hypothèse est que l’agrandissement de la valve mitrale en IA est un phénomène actif avec réactivation des mécanismes de croissance embryonnaire. Cent-onze rats ont été divisés en deux groupes : IA (perforation aortique) et contrôle. Les animaux ont été sacrifiés à 48 h, 1 semaine et 3 mois après la création du modèle. Des échocardiographies ont évalué la sévérité de l’IA, la présence d’IM et les dimensions du VG. Les valves ont été prélevées pour analyses microscopiques et moléculaires. La création de l’insuffisance aortique a entrainé une dilatation et une hypertrophie du VG. Malgré cette dilatation rapide du VG, aucun animal n’a développé de l’IM fonctionnelle. À l’échographie, le feuillet antérieur mitral était significativement plus long dans les groupes IA. Par microscopie, les feuillets étaient plus épais dés la première semaine. L’IA était associée à une surexpression de collagène α-SMA (un marqueur de myofibroblastes), TGF-β1 et MMP-2 dans le tissu valvulaire dès la première semaine. Les valves exposées à l’IA étaient également positives pour ces différents facteurs dés les premiers jours. L’agrandissement de la VM est un phénomène actif qui survient rapidement après la création de l’IA, en parallèle de la dilatation du VG. La stimulation de cette croissance dans d’autres pathologies pourrait contribuer à prévenir l’IM fonctionnelle.

Two cases of right atrial myxoma in redo patients. A mere coincidence?

We describe two cases of right atrial myxoma in redo patients who had previously undergone to coronary artery by-pass grafting (CABGs) and mitral valve replacement respectively. Both of patients experienced effort dyspnea and were assessed by trans-thoracic echocardiography, revealing the right atrial masses. They were operated on for myxoma resection and postoperative course was uneventful. Our report deals with the interesting topic of the location of benign masses that are usually more common in the left atrium. Should we hypothesize that the right atrial manipulation during the previous surgery induces the onset of the right atrial mass? It is an interesting matter to debate.

Behind Recurrent Thromboembolic Events

We describe the case of a 68-year-old man, who presented with an ischemic stroke due to cardiac embolization related to mitral valve endocarditis. Blood cultures were always negative and post-operative valve histology did not show microorganisms. The patient also presented further recurrent peripheral embolic events. These clinical aspects were the first sign of a pancreas adenocarcinoma, which was only diagnosed in the clinical autopsy. In conclusion, these clinical findings of recurrent thromboembolic events with no microorganisms isolated suggests the diagnostic of a marantic endocarditis.

Importância do eletrocardiograma de doze derivações na localização da via acessória no padrão de Wolff-Parkinson-White

A ablação por cateter de radiofrequência tornou-se o tratamento de escolha para os pacientes com síndrome de Wolff-Parkinson-White, sintomáticos. A localização da via acessória a partir da morfologia do QRS no eletrocardiograma basal, torna-se útil para o planeamento do procedimento de ablação, por permitir um conjunto de informações que ajudam na escolha da melhor abordagem terapêutica, em particular no que respeita ao intervalo para a ablação, a necessidade de punção transeptal e o risco de bloqueio aurículo-ventricular, se a via acessória estiver próxima do nódulo aurículo-ventricular ou do feixe de His. Estão descritos vários algoritmos para prever a localização da via acessória a partir da análise da morfologia do QRS basal. Os seus autores relatam elevados índices de acerto, todavia, estudos subsequentes obtiveram resultados distintos, com índices de acerto menores. O presente estudo tem como objetivo principal a avaliação da capacidade diagnóstica do eletrocardiograma de doze derivações na localização da via acessória no padrão de Wolff- Parkinson-White. Os dados clínicos necessários a este estudo foram recolhidos no Serviço de Cardiologia do Centro Hospitalar S. João – EPE, através da consulta dos exames eletrocardiograma e estudo eletrofisiológico, nos indivíduos com diagnóstico prévio de síndrome de Wolff-Parkinson- White. Numa amostra formada por 111 indivíduos de ambos os géneros e com idade média de 36,54 (± 15,27) anos (idade mínima de 7 anos e idade máxima de 75 anos), procedeu-se à comparação da localização da via acessória no estudo eletrofisiológico, com a obtida pela aplicação dos algoritmos de Arruda et al., Boersma et al., Chiang et al., Ávila et al., Fitzpatrick et al., Iturralde et al. e Xie et al. (harmonizadas para todos os algoritmos, as localizações possíveis das vias acessórias). Em volta do anel mitral, encontravam-se distribuídas 59 vias acessórias (53,15%), sendo 52 as vias acessorias distribuídas em torno do anel tricúspide (46,85%). Nesta distribuição não se observaram diferenças estatisticamente significativas de acordo com o género. O acerto global em todos os algoritmos variou entre 27,00% a 47,00%, aumentando para 40,00% a 76,00%, incluindo as localizações adjacentes. A concordância entre os investigadores variou entre 40,00% a 80,00%, observando-se que em relação ao valor médio de concordância, os algoritmos com menores localizações possíveis para as vias acessórias, obtiveram melhor resultado (64,00%). O acerto para as vias acessórias septais (51 no total) variou entre 2,00% a 52,20% (aumentando para 5,90% a 90,20%, incluindo as localizações adjacentes). As vias acessórias direitas, 13 no total, obtiveram acerto entre 7,70% a 69,20% (aumentando para 42,90% a 100%, incluindo as vias acessórias adjacentes). Por último, as vias acessórios esquerdas, 47 no total, obtiveram acerto entre 21,70% a 54,50% (aumentando para 50,00% a 87,00%, incluindo as vias acessórias adjacentes). Para esta distribuição das vias acessórias (localização septal, direita e esquerda), não se observaram diferenças estatisticamente significativas, de acordo com o género. Os resultados obtidos revelam que todos os algoritmos obtiveram valores de acerto inferiores aos enunciados pelos seus autores, permitindo concluir que embora o eletrocardiograma constitua um método muito importante no diagnóstico da pré-excitação ventricular do tipo Wolff-Parkinson-White, este não é sensível, nem específico para a deteção da localização da via acessória.

La ateromatosis aórtica aumenta el riesgo de ataque cerebrovascular isquémico

Antecedentes: el ataque cerebrovascular isquémico (ACVi) es causa de mortalidad y discapacidad importante en adultos, siendo la cardioembolia, sobre todo por fibrilación auricular (FA), una etiología importante. Se conocen otras etiologías, cardíacas y no cardíacas, que no siempre pueden definirse, refiriéndose como probables o posibles de cardioaortoembolia. El rol de alguna de ellas, como la ateromatosis aórtica (AA), continúa siendo discutido. Objetivo: analizar fuentes posibles de cardioaortoembolia en pacientes con ACVi reciente. Material y método: estudio caso-control. Se analizaron 100 sujetos con ACVi de menos de 30 días de evolución estudiados prospectivamente con ecocardiograma transesofágico (ETE), entre febrero de 2012 y marzo de 2014. Se apareó cada caso según edad, sexo, presencia de flutter/FA y ausencia de prótesis valvular cardíaca, con un control que se buscó retrospectiva y aleatoriamente entre sujetos con ETE estudiados entre 2010 y 2015 sin ACVi. Se compararon variables binarias mediante test de McNemar y las cuantitativas por test de t pareado; se realizó regresión logística múltiple para ACVi con variables clínicas y hallazgos de ETE y p < 0,1 en el análisis univariado. Se consideró significativo p < 0,05. Variables cuantitativas se expresan en media y desvío estándar (DE) y nominales en valor absoluto y porcentaje, índice de probabilidad (OR) en su valor e intervalo de confianza (IC) 95%. Resultados: se formaron finalmente 76 pares caso-control. Edad casos: 64,3±1,4 y control 64,9±1,3 años (p=0,19); 39 mujeres (51,3%) y 15 sujetos (19,7%) con flutter/FA en cada grupo (p=1). No hubo diferencias significativas según factores de riesgo cardiovascular (FRCV) globales (p=0,06) ni alcoholismo (p=0,80); se encontraron diferencias significativas en la prevalencia de dislipemia (p=0,03) e hipertensión arterial (HTA) (p <0,05). Las indicaciones principales del ETE en los controles fueron: previo a cardioversión eléctrica de FA, sospecha de endocarditis, y valoración de valvulopatía mitral. La ateromatosis aórtica proximal y compleja (AAPC) (p=0,002, OR 5,5, IC95% 1,9-15,9) y la AA en forma global (p=0,001, OR 4,1, IC95% 1,8-9,3), además de la dislipemia (p=0,02, OR 2,8 IC95% 1,2-6,4), se asociaron significativamente con la presencia de ACVi en el análisis multivariado. Conclusión: la AA aumenta significativamente las chances de ACVi y las quintuplica cuando es proximal y compleja. La dislipemia se asoció a ACVi.

Oral Anticoagulation in the Elderly: New Oral Anticoagulants-Innovative Solution for an Old Problem?

Direct oral anticoagulants emerge as the most innovative and promising drug toward preventing and treating cardiovascular disease, raising great interest among the scientific community. Numerous studies and meta-analysis generated much data clarifying clinicians' doubts; however, uncertainties remain regarding their use in particular groups such as patients with prosthetic valves, in valvular atrial fibrillation (defined as atrial fibrillation related to mitral rheumatic heart disease or prosthetic heart valves), among the elderly, in paraneoplastic thromboembolism, in pulmonary embolism with hemodynamic compromise, and scarcity of specific antidotes. This review article intends to condense the vast scientific production addressing new oral anticoagulants by focusing on their advantages and disadvantages when used on the elderly.

Disfunción diastólica en pacientes con hipertensión arterial grado I - II Hospital José Carrasco Arteaga, Cuenca 2006

Estudio descriptivo realizado con el objetivo de determinar la prevalencia de disfunción diastólica en pacientes con hipertensión arterial grado I-III, en edades de 30-60 años; a través de ecocardiograma doppler pulsado de flujo transvalvular mitral, hospital José Carrasco Arteaga, Cuenca 2006. Los pacientes fueron 76 seleccioados por asignación secuencial. Resultados: la edad media de los pacientes fue de 51 +- 6 años; 61,3corresponde al sexo femenino; con un índice de masa corporal de 26 kg (talla)2; el 60con hipertensión grado I y 40grado II; 72,5presentó hipertrofia ventricular izquierda; la alteración diastólica fue de 86,3(grado I 85,4y grado II 87,5), con predominio de patrón de relajación retardada (58,8). Conclusiones: el 86,3de pacientes con hipertensión arterial presentan disfución diastólica; con mínima diferencia entre hipertensión grado I y II (85,4y 87,5); concluyendo que a mayor grado de hipertensión arterial menor porcentaje de patrón normal de función diastólica, al igual que a mayor tiempo de hipertensión arterial (mayor de 10 años) mayor grado de disfunción diastólica. El patrón de disfunción diastólica predominante en hipertensión arterial grado I y II fue el de relajación retardada; incluso independientemente del peso

Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implications

Data are lacking on the characteristics of atrial activity in centenarians, including interatrial block (IAB). The aim of this study was to describe the prevalence of IAB and auricular arrhythmias in subjects older than 100 years and to elucidate their clinical implications. We studied 80 centenarians (mean age 101.4 ± 1.5 years; 21 men) with follow-ups of 6–34 months. Of these 80 centenarians, 71 subjects (88.8%) underwent echocardiography. The control group comprised 269 septuagenarians. A total of 23 subjects (28.8%) had normal P wave, 16 (20%) had partial IAB, 21 (26%) had advanced IAB, and 20 (25.0%) had atrial fibrillation/flutter. The IAB groups exhibited premature atrial beats more frequently than did the normal P wave group (35.1% vs 17.4%; P < .001); also, other measurements in the IAB groups frequently fell between values observed in the normal P wave and the atrial fibrillation/flutter groups. These measurements included sex preponderance, mental status and dementia, perceived health status, significant mitral regurgitation, and mortality. The IAB group had a higher previous stroke rate (24.3%) than did other groups. Compared with septuagenarians, centenarians less frequently presented a normal P wave (28.8% vs 53.5%) and more frequently presented advanced IAB (26.3% vs 8.2%), atrial fibrillation/flutter (25.0% vs 10.0%), and premature atrial beats (28.3 vs 7.0%) (P < .01). Relatively few centenarians (<30%) had a normal P wave, and nearly half had IAB. Our data suggested that IAB, particularly advanced IAB, is a pre–atrial fibrillation condition associated with premature atrial beats. Atrial arrhythmias and IAB occurred more frequently in centenarians than in septuagenarians.

Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation

The aim of this study is to describe the characteristics of infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI). This study was performed using the GAMES database, a national prospective registry of consecutive patients with IE in 26 Spanish hospitals. Of the 739 cases of IE diagnosed during the study, 1.3% were post-TAVI IE, and these 10 cases, contributed by five centres, represented 1.1% of the 952 TAVIs performed. Mean age was 80 years. All valves were implanted transfemorally. IE appeared a median of 139 days after implantation. The mean age-adjusted Charlson comorbidity index was 5.45. Chronic kidney disease was frequent (five patients), as were atrial fibrillation (five patients), chronic obstructive pulmonary disease (four patients), and ischaemic heart disease (four patients). Six patients presented aortic valve involvement, and four only mitral valve involvement; the latter group had a higher percentage of prosthetic mitral valves (0% vs. 50%). Vegetations were found in seven cases, and four presented embolism. One patient underwent surgery. Five patients died during follow-up: two of these patients died during the admission in which the valve was implanted. Conclusions: IE is a rare but severe complication after TAVI which affects about 1% of patients and entails a relatively high mortality rate. IE occurred during the first year in nine of the 10 patients.